Two years ago,
Yonge Street reported on a $27.9-million expansion
planned by Therapure Biopharma of its biomanufacturing facility in Mississauga. Late last month, that facility officially opened
to pursue research and manufacturing of protein-based bioproducts to meet global demand to treat infectious diseases.
The facility was completed with the help of a $4.2-million grant from the provincial ministry of Economic Development and Innovation. "Ontario's support for Therapure has built upon our strengths in research and manufacturing to help its global clients bring new, innovative medical treatments to patients," said Minister Brad Duguid in a statement.
The company expects the new capacity will double its staff over the next two years to about 200. The company has long been on a growth trajectory: from 13 employees in 2007 to 100 today. "Therapure is thrilled to officially celebrate the opening of its additional Custom Biologics Manufacturing Wing, which will enhance the company's ability to be an international leader in biomanufacturing and meet the needs of a growing market," said company president and CEO Nick Green in the announcement.
Writer: Edward Keenan
Sources: Office of the Minister of Economic Development and Innovation Brad Duguid; Thomas Wellner, former president and CEO, Therapure Biopharma Inc.